Department of Plastic Surgery, The Children's Hospital of Zhejiang University School of Medicine, Zhejiang, China.
Department of Cardiac Surgery, The Children's Hospital of Zhejiang University School of Medicine, Zhejiang, China.
Vaccine. 2017 Dec 4;35(48 Pt B):6594-6597. doi: 10.1016/j.vaccine.2017.08.011. Epub 2017 Oct 16.
Kasabach-Merritt phenomenon (KMP) is a rare potentially life-threatening consumptive coagulopathy characterized by thrombocytopenia and hypofibrinogenemia occurring associated with the vascular tumors kaposiform hemangioendothelioma (KHE) and tufted angioma (TA). A 10-month old male infant, diagnosed with KHE on his left leg, underwent a rapid increase of the lesion and severe thrombocytopenia, one day after the first dose of inactivated Japanese encephalitis (JE) vaccination. The episode of KMP was treated successfully by steroid. KMP is a rare complication of vaccination that physicians should be aware of. Giving up the following vaccination to provide the recurrence of KMP is not recommended.
卡波西-梅里特现象(KMP)是一种罕见的潜在危及生命的消耗性凝血障碍,其特征是血小板减少症和低纤维蛋白原血症,与血管肿瘤卡波西样血管内皮细胞瘤(KHE)和丛状血管瘤(TA)相关。一名 10 个月大的男婴,其左腿患有 KHE,在接种第一剂灭活日本脑炎(JE)疫苗后一天,病变迅速增加并出现严重血小板减少症。通过类固醇成功治疗了 KMP 发作。KMP 是疫苗接种的罕见并发症,医生应予以注意。为了防止 KMP 复发而放弃接种疫苗是不推荐的。